2026 · 3rd Quarter (July 1 - Sep 30)
Filed by VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC).
Open official filingSource-reported fields
Literal source text
Policies and regulations impacting clinical laboratories and drug testing, including issues related to HHS and DOT; H.R.4320, Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025; DOT Rule 49 CFR Part 40 Section 40.82.
Literal federal measure citations: H.R.4320
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
